Skip to content

Myocardial protective effect of sevoflurane in off-pump coronary artery bypass grafting

Myocardial protective effect of sevoflurane in off-pump coronary artery bypass grafting

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TTRCC-12002691
Enrollment
Unknown
Registered
2012-11-16
Start date
2010-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease

Interventions

control:no
0.75 MACgroup:Sevoflurane for Inhalation
1.0 MACgroup:Sevoflurane for Inhalation

Sponsors

The First Affiliated Hospital of Xinjiang Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) lesions in 2 or more coronary artery branches, or in the left coronary artery trunk; (2) recent myocardial infarction or unstable angina; (3) obvious regional left ventricular wall motion abnormality; (4) ejection fraction (EF) > 40% in pre-operative echocardiography.

Exclusion criteria

Exclusion criteria: severe arrhythmia, valvular lesions, concomitant congenital heart disease, severe peripheral vascular occlusive disease, patients receiving intra-aortic balloon pumping (IABP), intra-operative change into cardiopulmonary bypass, intra-operative administration of adrenaline, stroke patients, and patients with diabetes mellitus.

Design outcomes

Primary

MeasureTime frame
brain natriuretic peptid;

Countries

China

Contacts

Public ContactJiang Wang
710985359@qq.com+86 18991985269

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026